In Vitro & In Vivo Diagnostic Substances Industry - Insider Stock Trading - OpenInsider

14 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	#f	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
5/19/25 13:23	5/19/25	VNRX	Volitionrx Ltd	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Micallef Jacob Vincent	NV	O	Chief Sc	1	P	22	0.4300	0	50	11	519	D
5/19/25 12:43	5/19/25	VNRX	Volitionrx Ltd	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Reynolds Cameron John	NV	DO	P,CEO	2	P	109	0.5388	0	202	6	3,361	D
5/12/25 14:30	5/12/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Gupta Aashima	MI	D		1	P	100	6.25	0	16	270	22	D
4/25/25 16:32	4/25/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Woteki Catherine E	MI	D		1	P	30	5.17	0	6	77	13	D
4/25/25 14:45	4/24/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Borel James C	MI	D		2	P	321	4.94	0	65	255	90	D
4/24/25 15:34	4/24/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Boehm William T	MI	D		1	P	26	5.24	0	5	16	36	D
4/23/25 10:46	4/23/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Rocklin Amy M	MI	O	GC	1	P	62	4.99	0	13	53	36	D
4/22/25 15:37	4/22/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Capello Jeffrey D	MI	D		1	P	100	4.84	0	21	350	27	D
4/22/25 11:46	4/22/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		1	P	47	4.73	0	10	36	37	D
4/22/25 11:43	4/22/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Rodriguez Rafael A	MI	D		1	P	34	4.59	0	7	100	15	D
4/10/25 10:12	4/10/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Moylan John Patrick	MI	O	Chief Ac	1	P	51	5.07	0	10		10	D
3/27/25 08:13	3/26/25	VNRX	Volitionrx Ltd	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Innes Guy Archibald	NV	D		1	P	100	0.5500	0	182	6	3,243	D
3/19/25 16:38	3/17/25	ACHV	Achieve Life Sciences, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Oki Mark K	WA	O	CFO	1	P	29	2.89	0	10		10	D
3/19/25 16:32	3/17/25	ACHV	Achieve Life Sciences, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Stewart Richard Alistair	WA	DO	Chieve E	1	P	29	2.86	0	10	19	62	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact